IP Library Granted Patent US 8,440,787
Granted Patent B2
US 8,440,787 · App. 12/738,980 · Granted May 14, 2013

Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,787
App. No.
12/738,980
Granted
May 14, 2013
Kind
B2
Abstract

The present invention provides hydmoxyapatite-targeting, multiarm polymer reagents suitable for reaction with biologically active agents to form conjugates, the polymeric reagents comprising one or more polymer chains and a plurality of hydroxyapatile-targeting moieties located at the terminus of one or more of the polymer chains. The multiarm polymers are optionally divided or separated by one or more degradable linkages into polymer segments having a molecular weight suitable for renal clearance. The polymeric reagents of the invention can have a substantially linear structure, although branched or multiarm structures are contemplated as well. The invention is suited for applications in which use of a high molecular weight polymer is desired, such as a total polymer number average molecular weight of at least about 30,000 Da for linear polymers and 20,000 Da for multiarm polymers. Each structure includes one or more linkages capable of degradation in vivo. The use of multiple hydroxyapatite-targeting moieties on each polymer molecule enhances the ability of the polymer reagent to selectively target and bind to hydroxyapatite surfaces, which in turn, can increase the concentration of biologically active moiety delivered to the bone site.

Claims (30)

1. A polymer having the structure:

wherein:

A is —(X 3 ) d -(L 3 ) e -(X 4 ) f -POLY 2 -Z 2 or —(X 3 ) d -(L 3 ) e -(X 4 ) f —Z 2 each POLY 1 and POLY 2 , which may be the same or different, is a water-soluble, non-peptidic polymer;

each X 1 , X 2 , X 3 , and X 4 , which may be the same or different, is a spacer moiety;

each L 1 , L 2 , and L 3 , which may be the same or different, are linkages;

each Z 1 is selected from a multiarm structure selected from the group consisting of

wherein each m is 1-350, Me is methyl, and each Z is a hydroxyapatite-targeting moiety with the proviso that at least one Z 1 is a hydroxyapatite-targeting moiety;

Z 2 is a functional group, optionally attached to POLY 2 through a spacer moiety;

each a, b, c, d, e, and f, which may be the same or different, is either zero or one;

R is a monomeric or oligomeric multiarm core molecule derived from a molecule comprising at least p+1 sites available for attachment; and

p is an integer in the range of 2-32.

2. The polymer of claim 1 , wherein each POLY 1 and POLY 2 , when present, has a number average molecular weight of less than about 22,000 Da.

3. The polymer of claim 2 , wherein each POLY 1 and POLY 2 , when present, has a number average molecular weight of less than about 15,000 Da.

4. The polymer of claim 3 , wherein each POLY 1 and POLY 2 , when present, has a number average molecular weight of less than about 8,000 Da.

5. The polymer of claim 1 , wherein each Z 1 is independently selected from the group consisting of tetracycline, calcein, bisphosphonates, polyaspartic acid, polyglutamic acid, and aminophosphosugars.

6. The polymer of claim 1 , wherein at least one of L 1 , L 2 , and L 3 is hydrolytically or enzymatically cleavable.

7. The polymer of claim 1 , wherein one or both of POLY 1 and POLY 2 , when present, have a segmented structure comprising two to about five water-soluble, non-peptidic polymer segments attached through linkages.

8. The polymer of claim 7 , wherein one or both of POLY 1 and POLY 2 , when present, have a structure according to the formula -POLY-L-POLY-, wherein each POLY is a water-soluble, non-peptidic polymer and L is a linkage.

9. The polymer of claim 1 , wherein each POLY 1 and POLY 2 , when present, are polymers independently selected from the group consisting of poly(alkylene glycols), poly(olefinic alcohol), poly(vinylpyrrolidone), poly(hydroxyalkylmethacrylamide), poly(hydroxyalkylmethacrylate), poly(saccharides), poly(α-hydroxy acid), poly(acrylic acid), poly(vinyl alcohol), polyphosphazene, polyoxazoline, poly(N-acryloylmorpholine), and copolymers, terpolymers, or mixtures thereof.

10. The polymer of claim 1 , wherein each POLY 1 and POLY 2 , when present, is poly(ethylene glycol).

11. The polymer of claim 1 , wherein each POLY 1 and POLY 2 , when present, has the structure —CH 2 CH 2 O(CH 2 CH 2 O) n —CH 2 CH 2 —, where n is 1-350.

12. The polymer of claim 1 , wherein p is 3 to about 10.

13. The polymer of claim 1 , wherein R is derived from a polyol with the structure R 1 (OH) p , wherein R is a branched hydrocarbon, optionally including one or more ether linkages, and p is at least 3.

14. The polymer of claim 13 , wherein the polyol is selected from the group consisting of glycerol, pentaerythritol, and sugar-derived alcohols, and oligomers or polymers of each of the foregoing.

15. The polymer of claim 1 , wherein p is 2 to about 10, and R is derived from a molecule selected from the group consisting of polyols, disulfides, and peptides, and oligomers or polymers of each of the foregoing, and combinations thereof.

16. The polymer of claim 1 , wherein R is derived from a di-peptide or tri-peptide comprising at least one lysine residue.

17. A polymer having the structure

wherein n is 1-350.

18. A polymer having the structure

wherein n is 1-350.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2010
From: MCMANUS, SAMUEL P.; KOZLOWSKI, ANTONI
To: NEKTAR THERAPEUTICS
Reel/Frame 024756/0717 →